Diagnostic marker cooperative study for the diagnosis of myocardial infarction

Area of Science:

• Cardiology
• Clinical Diagnostics
• Biomarker Research

Background:

• Chest pain is a common emergency department complaint, with myocardial infarction (MI) present in only 10-15% of cases.
• Current diagnostic markers for MI lack sufficient sensitivity and specificity, leading to treatment delays and unnecessary hospital admissions.
• Comparative data on novel cardiac biomarkers are scarce, yet utilizing all available markers is impractical and costly.

Purpose of the Study:

• To compare the diagnostic performance of various cardiac biomarkers for chest pain evaluation.
• To determine the sensitivity and specificity of creatine kinase-MB (CK-MB) subforms, myoglobin, total CK-MB, troponin T, and troponin I.
• To assess the utility of these markers in identifying myocardial infarction and unstable angina.

Main Methods:

• Prospective, multicenter, double-blind study enrolling 955 patients with chest pain.
• Serial sampling of biomarkers (CK-MB subforms, myoglobin, total CK-MB, troponin T, troponin I) for up to 24 hours.
• Analysis of diagnostic sensitivity, specificity, and marker elevation frequency in patients with unstable angina.

Main Results:

• CK-MB subforms demonstrated the highest sensitivity (91%) and specificity (89%) within 6 hours of symptom onset.
• Myoglobin was also highly sensitive and specific in early diagnosis (78% and 89%).
• For late diagnosis (10-18 hours), total CK-MB activity (96% sensitivity, 98% specificity) and troponin I (96% sensitivity, 93% specificity) showed superior performance.

Conclusions:

• The CK-MB subform assay, alone or combined with troponin, can reliably triage chest pain patients.
• This approach has the potential to improve patient therapy and reduce healthcare costs.
• Early and accurate diagnosis of cardiac events is crucial for effective management.